www.fdanews.com/articles/87563-biocryst-pharmaceuticals-enter-agreement-with-green-cross-to-develop-and-commericalize-peramivir
BIOCRYST PHARMACEUTICALS ENTER AGREEMENT WITH GREEN CROSS TO DEVELOP AND COMMERICALIZE PERAMIVIR
June 14, 2006
BioCryst Pharmaceuticals (Nasdaq: BCRX) announced an agreement with Green Cross Corporation, South Korea for the development and commercialization in Korea of peramivir, BioCryst's potent influenza neuraminidase inhibitor.
StreetInsider.com (http://www.streetinsider.com/news.php?id=963334&st=p)